About this Journal Submit a Manuscript Table of Contents
Structural Biology
Volume 2013 (2013), Article ID 810691, 11 pages
http://dx.doi.org/10.1155/2013/810691
Research Article

A Quantitative Structure-Activity Relationship and Molecular Modeling Study on a Series of Biaryl Imidazole Derivatives Acting as H+/K+-ATPase Inhibitors

1Department of Biotechnology, Meerut Institute of Engineering and Technology, Meerut 250005, India
2Department of Pharmaceutical Technology and Department of Applied Sciences, Meerut Institute of Engineering and Technology, Meerut 250005, India

Received 17 September 2012; Revised 23 November 2012; Accepted 26 November 2012

Academic Editor: Shandar Ahmad

Copyright © 2013 Neeraj Agarwal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Garton, N. Bailey, M. Bamford et al., “Discovery of biaryl inhibitors of H+/K+ATPase,” Bioorganic and Medicinal Chemistry Letters, vol. 20, no. 3, pp. 1049–1054, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Zimmermann, W. Buhr, C. Brehm, et al., “Novel indanyl-substituted imidazo [1, 2-a] pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase,” Bioorganic & Medicinal Chemistry Letters, vol. 17, no. 19, pp. 5374–5378, 2007. View at Publisher · View at Google Scholar
  3. M. R. S. Nayana, Y. N. Sekhar, H. Nandyala et al., “Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies,” Journal of Molecular Graphics and Modelling, vol. 27, no. 3, pp. 233–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. V. Esplugues, “A pharmacological approach to gastric acid inhibition,” Drugs, vol. 65, no. 1, pp. 7–12, 2005. View at Scopus
  5. W. Beil, I. Hackbarth, and K. F. Sewing, “Mechanism of gastric antisecretory effect of SCH 28080,” British Journal of Pharmacology, vol. 88, no. 1, pp. 19–23, 1986. View at Scopus
  6. B. Wallmark, C. Briving, J. Fryklund, K. Munson, R. Jackson, and J. Mendlein, “Inhibition of gastric H+, K+-ATPase and acid secretion by SCH, 28080, a substituted pyridyl(1, 2a)imidazole,” The Journal of Biological Chemistry, vol. 262, no. 5, pp. 2077–2084, 1987.
  7. A. W. Herling and K. Weidmann, “Gastric proton pump inhibitors,” in Burger's Medicinal Chemistry and Drug Discovery, M. E. Wolff, Ed., vol. 2, pp. 122–134, John Wiley & Sons, New York, NY, USA, 5th edition, 1996.
  8. J. Mossner and K. Caca, “Developments in the inhibition of gastric acid secretion,” European Journal of Clinical Investigation, vol. 35, no. 8, pp. 469–475, 2005. View at Publisher · View at Google Scholar
  9. K. Andersson and E. Carlsson, “Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases,” Pharmacology and Therapeutics, vol. 108, no. 3, pp. 294–307, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. P. J. Zimmermann, C. Brehm, W. Buhr, A. M. Palmer, J. Volz, and W. A. Simon, “Novel imidazo[1,2-a]pyrazine derivatives as potent reversible inhibitors of the gastric H+/K+-ATPase,” Bioorganic and Medicinal Chemistry, vol. 16, no. 1, pp. 536–541, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Lindberg, A. Brandstrom, B. Wallmark, H. Mattsson, L. Rikner, and K. J. Hoffmann, “Omeprazole: the first proton pump inhibitor,” Medicinal Research Reviews, vol. 10, no. 1, pp. 1–54, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. T. N. Ojha, R. C. Sharma, and P. Singh, “Quantitative structure-activity relationship study of 2-[(2-benzimidazolylsulphinyl)methyl]-aniline inhibitors of H+/K+-Aptase,” Drug Design and Delivery, vol. 6, no. 4, pp. 289–296, 1990.
  13. P. Singh, R. C. Sharma, and T. N. Ojha, “Qunatative structure activity relationship studies of inhibitors of (H+/K+)-Aptase,” Drug Design and Delivery, vol. 7, no. 2, pp. 131–138, 1991.
  14. T. N. Ojha, P. Singh, and R. C. Sharma, “Structure-activity relationship studies of 4-substituted-2-guanidinothiazoles: reversible inhibitors of gastric (H+/K+)-ATPase,” Indian Journal of Biochemistry and Biophysics, vol. 30, no. 4, pp. 239–243, 1993. View at Scopus
  15. E. G. Borges and Y. Takahata, “QSAR study of anti-ulcer compounds using calculated parameters,” Journal of Molecular Structure, vol. 539, no. 1–3, pp. 245–251, 2001. View at Publisher · View at Google Scholar
  16. E. G. Borges and Y. Takahata, “The 4-indolyl-2-guanidinothiazoles QSAR study of anti-ulcer activity using quantum descriptors,” Journal of Molecular Structure, vol. 580, no. 1–3, pp. 263–270, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Sharma, S. Singh, T. I. Siddiqui et al., “α-Amino acid derivatives as proton pump inhibitors and potent anti-ulcer agents,” European Journal of Medicinal Chemistry, vol. 42, no. 3, pp. 386–393, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. S. Nayana, Y. N. Sekhar, H. Nandyala et al., “Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies,” Journal of Molecular Graphics and Modelling, vol. 27, no. 3, pp. 233–243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. http://www.vcclab.org/lab/edragon/.
  20. http://apodvision.com/apod/apod.pl.